BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 30

• Genetown

  Advanced Cell Technology Files IND With FDA For First Human Clinical Trial Using Embryonic Stem Cells to Treat Eye Disease

  November 19, 2009

   · 

  1 min read
• Chemical Computing Group Inc. Releases GOLD Integration Technology

  November 19, 2009

   · 

  1 min read
• Biotech Bay

  Quark Pharmaceuticals Inc. Reports Progress of siRNA Clinical Programs

  November 19, 2009

   · 

  3 min read
• Genetown

  VisEn Medical, Inc. Launches New OsteoSense(R) 800 and VivoTag(R) 800 Fluorescence Molecular Imaging Agents Expands VisEn’s Fluorescence Molecular Imaging Agent Portfolio to Enable Enhanced Multiplexed Readouts of Key Biomarkers in Research and Drug Devel

  November 19, 2009

   · 

  1 min read
• Bio NC

  nContact Surgical, Inc. Results Presented from First Study Reviewing Convergent Approach to Treating Atrial Fibrillation at American Heart Association Scientific Sessions

  November 19, 2009

   · 

  1 min read
• Drug Development

  AFFiRiS GmbH: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer’s Vaccine Candidate AD02 into Clinical Phase II Testing

  November 19, 2009

   · 

  3 min read
• Drug Development

  Thallion Pharmaceuticals Inc. Presents Poster on the Apoptotic Properties of TLN-4601 at the AACR-NCI-EORTC Conference

  November 19, 2009

   · 

  4 min read
• Cellectis BioResearch European Patent EP 1 485 475 upheld against Precision BioSciences at European Patent Office

  November 19, 2009

   · 

  1 min read
• Biotech Bay

  AnaSpec, Inc. Introduces SensoLyte 520 Calpain Kit

  November 19, 2009

   · 

  3 min read
• Genetown

  Paloma Pharmaceuticals, Inc. Presents at the AACR-NCI-EORTC International Conference Molecular Targets and Cancer Therapeutics

  November 19, 2009

   · 

  3 min read